Home › Companies › RELAY THERAPEUTICS INC. › 2023-2024

RELAY THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and RELAY THERAPEUTICS INC.’s Form 8-K, filed 2024-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.

4Ballot items
201Asset managers
1,118Fund votes
2024-06-03Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore RELAY THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by RELAY THERAPEUTICS INC.

These tallies are RELAY THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

RELAY THERAPEUTICS INC. — official shareholder meeting results, meeting held 2024-06-03
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Sanjiv K. Patel, M.D.	109,894,794	--	--	1,587,504	8,190,121	Majority: yes
Elect Director: Linda A. Hill, Ph.D.	91,335,004	--	--	20,111,439	8,225,976	Majority: yes
Proposal 2. Non-binding advisory vote on executive compensation.	66,749,846	44,678,968	53,582	--	8,190,023	Majority: yes
Proposal 3. Ratification of appointment of independent registered public accounting firm.	119,407,293	19,856	245,270	--	--	Majority: yes

Source: RELAY THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-03 — read the filing on EDGAR.

How asset managers voted at the RELAY THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 201 asset managers that disclosed a RELAY THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To consider and act upon an advisory vote on the compensation of our named executive officers;

COMPENSATIONMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%AGAINST 40%

FOR: 66,749,846AGAINST: 44,678,968

RELAY THERAPEUTICS INC.’s own tally for this item (“Proposal 2. Non-binding advisory vote on executive compensation.”): 66,749,846 for, 44,678,968 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,300,851 outstanding shares: 50.5% for, 34% against (84% of the company cast a for/against vote).

The 197 asset managers below cast 49.1% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 49.1%AGAINST 50.9%

FOR: 49.1%AGAINST: 50.9%ABSTAIN: 0.0%

Largest asset managers voting on “To consider and act upon an advisory vote on the compensation of our named executive officers;” at RELAY THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
SB INVESTMENT ADVISERS (UK) LTD	27,904,963	0	For
Vanguard	11,865,044	1,539,365	For
T. Rowe Price	0	11,450,693	Against
State Street	82,276	9,341,090	Against
BlackRock	49,087	6,927,597	Against
Bellevue Group AG	5,925,000	1,618	For
JPMorgan	5,677,754	0	For
ArrowMark Colorado Holdings LLC	0	3,821,319	Against
Fidelity	918,367	2,152,432	Against
BRAIDWELL LP	0	2,465,673	Against
GEODE CAPITAL MANAGEMENT, LLC	0	2,021,853	Against
Charles Schwab	0	1,831,796	Against
GV Management Company, L.L.C.	1,564,173	0	For
Finepoint Capital LP	0	1,490,170	Against
Dimensional	0	1,326,874	Against
Goldman Sachs	0	1,035,586	Against
JACOBS LEVY EQUITY MANAGEMENT, INC	0	938,844	Against
Point72	0	901,603	Against
MERIDIAN FUND INC	0	834,182	Against
Northern Trust	828,148	4,176	For
MPM BioImpact LLC	832,017	0	For
Federated Hermes	571,083	3,622	For
Prudential/PGIM	0	543,418	Against
Candriam S.C.A.	0	508,400	Against
BESSEMER TRUST CO	0	457,869	Against

Showing the 25 largest of 197 asset managers. See all 197 in the interactive database.

2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 119,407,293AGAINST: 19,856

RELAY THERAPEUTICS INC.’s own tally for this item (“Proposal 3. Ratification of appointment of independent registered public accounting firm.”): 119,407,293 for, 19,856 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,300,851 outstanding shares: 90% for, 0.1% against (90% of the company cast a for/against vote).

The 67 asset managers below cast 100% of the shares they voted on this item FOR (38,738,613 for, 0 against).

FOR 99.9%

FOR: 38,738,613 (100.0%)ABSTAIN: 14,951 (0.0%)

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at RELAY THERAPEUTICS INC., 2023-2024
Asset manager	For	Vote
Vanguard	13,260,537	For
T. Rowe Price	4,985,365	For
State Street	3,813,297	For
BlackRock	3,563,309	For
JPMorgan	2,813,386	For
Fidelity	2,525,128	For
Dimensional	1,027,618	For
Charles Schwab	915,898	For
MERIDIAN FUND INC	834,182	For
Goldman Sachs	572,628	For
Columbia Threadneedle	439,242	For
AIG/SunAmerica	326,310	For
Equitable	308,892	For
TIAA	258,470	For
Federated Hermes	251,140	For
Brinker Capital Destinations Trust	241,247	For
Prudential/PGIM	206,368	For
Direxion Shares ETF Trust	188,503	For
Nationwide	185,478	For
DRIEHAUS MUTUAL FUNDS	159,877	For
American Century	149,712	For
Jackson National	134,129	For
John Hancock	130,950	For
First Trust	118,644	For
SEI	118,556	For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

3. To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Linda A. Hill, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%

FOR: 91,335,004WITHHELD: 20,111,439

RELAY THERAPEUTICS INC.’s own tally for this item (“Elect Director: Linda A. Hill, Ph.D.”): 91,335,004 for, 20,111,439 withheld, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,300,851 outstanding shares: 69% for, 15% withheld (84% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (31,051,461 for, 0 against).

FOR 80%ABSTAIN 20%

FOR: 31,051,461 (80.1%)ABSTAIN: 7,694,619 (19.9%)

Largest asset managers voting on “To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholde” at RELAY THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	13,260,537	0	For
T. Rowe Price	4,985,365	0	For
State Street	3,757,955	55,342	For
BlackRock	0	3,563,309	Abstain
JPMorgan	2,813,386	0	For
Fidelity	2,464,723	60,405	For
Dimensional	0	1,027,618	Abstain
Charles Schwab	915,898	0	For
MERIDIAN FUND INC	834,182	0	For
Goldman Sachs	0	572,628	Abstain
Columbia Threadneedle	439,242	0	For
AIG/SunAmerica	0	326,310	Abstain
Equitable	30,792	278,100	Abstain
TIAA	258,470	0	For
Federated Hermes	251,140	0	For
Brinker Capital Destinations Trust	3,206	238,041	Abstain
Prudential/PGIM	181,739	24,629	For
Direxion Shares ETF Trust	0	188,503	Abstain
Nationwide	634	184,844	Abstain
DRIEHAUS MUTUAL FUNDS	0	159,877	Abstain
American Century	0	149,712	Abstain
Jackson National	115,920	18,209	For
John Hancock	96,541	34,409	For
First Trust	0	118,644	Abstain
SEI	118,556	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

4. To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Sanjiv K. Patel, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 109,894,794WITHHELD: 1,587,504

RELAY THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sanjiv K. Patel, M.D.”): 109,894,794 for, 1,587,504 withheld, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 132,300,851 outstanding shares: 83% for, 1% withheld (84% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (37,661,272 for, 0 against).

FOR 97%

FOR: 37,661,272 (97.2%)ABSTAIN: 1,084,808 (2.8%)

Largest asset managers voting on “To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholde” at RELAY THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	13,260,537	0	For
T. Rowe Price	4,985,365	0	For
State Street	3,809,028	4,269	For
BlackRock	3,563,309	0	For
JPMorgan	2,813,386	0	For
Fidelity	2,525,128	0	For
Dimensional	0	1,027,618	Abstain
Charles Schwab	915,898	0	For
MERIDIAN FUND INC	834,182	0	For
Goldman Sachs	572,628	0	For
Columbia Threadneedle	439,242	0	For
AIG/SunAmerica	326,310	0	For
Equitable	308,892	0	For
TIAA	258,470	0	For
Federated Hermes	251,140	0	For
Brinker Capital Destinations Trust	241,247	0	For
Prudential/PGIM	206,368	0	For
Direxion Shares ETF Trust	188,503	0	For
Nationwide	185,478	0	For
DRIEHAUS MUTUAL FUNDS	159,877	0	For
American Century	149,712	0	For
Jackson National	115,920	18,209	For
John Hancock	130,950	0	For
First Trust	118,644	0	For
SEI	118,556	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

Largest RELAY THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked by the number of RELAY THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 132,300,851 shares outstanding at the time of that meeting.

Top RELAY THERAPEUTICS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	SB INVESTMENT ADVISERS (UK) LTD	21.09%
2	Vanguard	10.13%
3	T. Rowe Price	8.66%
4	State Street	7.12%
5	BlackRock	5.27%
6	Bellevue Group AG	4.48%
7	JPMorgan	4.29%
8	ArrowMark Colorado Holdings LLC	2.89%
9	Fidelity	2.32%
10	BRAIDWELL LP	1.86%

Reported RELAY THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

RELAY THERAPEUTICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	10.40%	13F
Vanguard Group	7.10%	13F
T. Rowe Price	5.20%	13F
State Street	4.55%	13F
Geode Capital	1.68%	13F
Goldman Sachs	1.41%	13F
Morgan Stanley	1.33%	13F
Norges Bank	1.22%	13F
Dimensional Fund Advisors	1.21%	13F
Point72	0.72%	13F

Percentages above are of 132,300,851 shares outstanding, as reported by RELAY THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from RELAY THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At RELAY THERAPEUTICS INC.'s shareholder meeting held 2024-06-03, in the 2023-2024 proxy season, 201 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,118 separate fund positions. On the most widely held item on that ballot — To consider and act upon an advisory vote on the compensation of our named executive officers; — FOR was 60% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: RELAY THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-03.

RELAY THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.